Ethylgallate

Ethylgallate

SCHEMBL7744669

CCOC(=O)c1cc(O)c(O)c(O)c1.Oc1cccc(O)c1O

nearest known ligand 0.83

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CA12 O43570 4/20 0.62
CA1 P00915 4/20 0.62
CA2 P00918 4/20 0.62
CA7 P43166 4/20 0.62
CA9 Q16790 4/20 0.62
CA14 Q9ULX7 4/20 0.62
SERPINE1 P05121 5/20 0.59
PTPN11 Q06124 1/20 0.58
ESR1 P03372 3/20 0.58
TYR P14679 2/20 0.56
AKR1C4 P17516 1/20 0.55
AKR1C3 P42330 1/20 0.55
AKR1C2 P52895 1/20 0.55
AKR1C1 Q04828 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.54
ESR2 Q92731 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylgallate SCHEMBL39599 0.91 SERPINE1 (0.70) CA12CA1CA2CA7CA9
Ethylgallate SCHEMBL27840060 0.89 SERPINE1 (0.68) CA12CA1CA2CA7CA9
Ethylgallate SCHEMBL29200753 0.87 SERPINE1 (0.66) CA12CA1CA2CA7CA9
Ethylgallate SCHEMBL29200784 0.87 SERPINE1 (0.66) CA12CA1CA2CA7CA9
Propyl Gallate SCHEMBL186140 0.87 ESR1 (0.69) SERPINE1ESR1TYRAKR1C4AKR1C3
Ethylgallate SCHEMBL28018664 0.86 SERPINE1 (0.63) CA12CA1CA2CA7CA9
Ethylgallate SCHEMBL26626292 0.84 SERPINE1 (0.61) CA12CA1CA2CA7CA9
Ethylgallate SCHEMBL3716520 0.84 KDM4E (0.75) CA12CA1CA2CA7CA9
Propyl Gallate SCHEMBL9232748 0.83 ESR1 (0.73) CA12CA1CA2CA7CA9
SCHEMBL15044101 0.82 CA12 (0.61) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001014510-A1 STRIPPING AND CLEANING COMPOSITIONS ASHLAND INC. (US) 2001-03-01 WO disclosed